conspiracy resource

Conspiracy News & Views from all angles, up-to-the-minute and uncensored

COVID-19

CDC Warns People With HIV Have a Higher COVID-19 Reinfection Chance

People with HIV have a higher chance of being reinfected with COVID-19, the CDC says.

The U.S. Centers for Disease Control and Prevention (CDC) found that people with HIV have a higher chance of being reinfected with COVID-19 than those who don’t have HIV.

A recent CDC study published in Emerging Infectious Diseases evaluated 453,587 adults in Chicago who were infected with COVID-19. They then looked at the COVID-19 testing results with Chicago’s AIDS and HIV reporting system.

“HIV can compromise the immune system; persons with HIV (PWH), especially those not receiving antiretroviral therapy (ART), might be vulnerable to SARS-CoV-2 infection,” the researchers wrote. “Understanding how COVID-19 affects PWH is important because approximately half of PWH are >50 years of age and have higher rates of medical comorbidities, compared with persons without HIV (PWOH).”

Related Stories

10/26/2023

COVID Hospitalizations Continue to Drop, CDC Data Show

10/26/2023

Meeting of the CDC Advisory Committee on Immunization Practices

They found that 5.3 percent of people who tested positive for COVID-19 were reinfected, including 6.7 percent of people with HIV and 5.2 percent of people without HIV.

Regardless of the COVID-19 variant wave and timing, people with HIV consistently had a higher rate of reinfection than those who don’t have HIV, the CDC said.

“Understanding if persons with HIV have a higher risk for SARS-CoV-2 reinfection may help tailor future COVID-19 public health guidance,” the authors wrote before recommending vaccines and boosters.

Health officials say HIV, or human immunodeficiency virus, can weaken the immune system by infecting CD4 cells, which causes one’s white blood cell count to drop.  The attacks on the immune system can lead to AIDS, or acquired immunodeficiency syndrome.

A number of studies have shown that people who have compromised immune systems are more susceptible to COVID-19.

“Evaluating the association between HIV infection and SARS-CoV-2 reinfections using surveillance data can help strengthen public health recommendations, including the need for extra doses as part of a primary series, booster doses of vaccine, and optimized [antiretroviral therapy] in [persons with HIV],” the authors wrote. “Tailored guidance and prevention messaging for [persons with HIV] can help reduce the elevated risk we identified in this analysis and limit continued SARS-CoV-2 transmission.”

A study from Spain recently found that people who with HIV who were diagnosed with HIV had a 35 percent higher chance of developing a major cardiovascular event in the following year compared with those who don’t have HIV. About a year before that, one from Johns Hopkins University found that people who have “moderate immune suppression appear to be at greater risk of severe COVID-19 ‘breakthrough’ infection after vaccination.”

Vaccine Uptake Low

The publication of the new CDC HIV and COVID-19 study comes as agency data shows that few Americans have received the latest booster shots made by Pfizer, Moderna, or Novavax. Seven percent of adults and 2 percent of children in the United States have received the latest shot as of mid-October, or about a month after the CDC and Food and Drug Administration (FDA) both signed off on the vaccines.

About 12 million people, or around 3.6 percent of the population, have gotten the shot, CDC Director Mandy Cohen told Politico. “I think we’re on track. Would I love to see more? Of course, that’s my job as CDC director is to want more,” she stated last week.
However, Pfizer, in an earnings report issued in October, slashed its guidance around is mRNA vaccines and other COVID-19 products amid lower demand. The firm expects sales of its COVID-19 vaccine will be about $2 billion lower than previously forecast.
“We are in the middle of the COVID fatigue. Nobody wants to speak about COVID,” Pfizer CEO Albert Bourla said during a call earlier this month, according to CNBC.

Hospitalizations for COVID-19 have continued to drop over the past several weeks after rising somewhat during the summer, according to data posted weekly by the CDC. Emergency room visits and case numbers have also dropped in recent weeks.

Meanwhile, a new COVID-19 variant called HV.1 is now spreading across the United States, according to a CDC update on Friday.

“COVID-19 variants continue to emerge but have not resulted in rapid disease surges,” the CDC said in an update. “We continue to anticipate a moderate COVID-19 wave, causing around as many hospitalizations at the peak as occurred at last winter’s peak.”
***
This article has been archived for your research. The original version from Epoch Times can be found here.